000			01906 a2200457 4500
005			20250515121408.0
264		0	_c20081014
008			200810s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2008.03.009 _2doi
040			_aNLM _beng _cNLM
100	1		_aKunnumakkara, Ajaikumar B
245	0	0	_aCurcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. _h[electronic resource]
260			_bCancer letters _cOct 2008
300			_a199-225 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAngiogenesis Inhibitors _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBreast Neoplasms _xprevention & control
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aClinical Trials as Topic
650	0	4	_aCurcumin _xchemistry
650	0	4	_aGastrointestinal Neoplasms _xprevention & control
650	0	4	_aHumans
650	0	4	_aInterleukins _xantagonists & inhibitors
650	0	4	_aMAP Kinase Signaling System _xdrug effects
650	0	4	_aNF-kappa B _xantagonists & inhibitors
650	0	4	_aNeoplasm Invasiveness
650	0	4	_aNeoplasm Metastasis _xprevention & control
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aPPAR gamma _xdrug effects
650	0	4	_aSTAT Transcription Factors _xantagonists & inhibitors
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTranscription Factor AP-1 _xantagonists & inhibitors
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
700	1		_aAnand, Preetha
700	1		_aAggarwal, Bharat B
773	0		_tCancer letters _gvol. 269 _gno. 2 _gp. 199-225
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2008.03.009 _zAvailable from publisher's website
999			_c17974501 _d17974501